So the fair summary for BPC-157 within KLOW is: strong and interesting preclinical data, a real mechanistic rationale, and a near-total absence of the human efficacy and safety evidence that would justify confidence in the systemic claims made for it
About Drugwatch.com 17 Years of Advocacy $324 Million Recovered for Clients 20,000 Families Helped A+ BBB Rating 4.9 Stars from Google Reviews Testimonials I found Drugwatch to be very helpful with finding the right lawyers
Oxygen gas was bubbled through aqueous solutions of NP2 and NP4 and the amount of trapped oxygen time-dependently quantified
The animal science is solid, but no large human trials have been completed, it's not FDA-approved, and the company that developed it walked away from it in the early 2000s
For guidance on how long peptides take to work , IGF-1 LR3 typically shows effects within the first few weeks, with peak benefits around weeks 3 to 4 of a cycle